Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC
In the Driver’s Seat With EGFR: Application of Mutation Testing to Treatment Selection for NSCLC
Click the "View Activity" button to view this activity.View Activity
CME/CE is no longer available for this activity
• Explain best practices for EGFR mutation testing in NSCLC
• Apply current evidence for selection of EGFR TKI therapy across patients with diverse EGFR mutations
• Discuss evidence supporting a role of TP53 in the prognosis of NSCLC and response to therapy
• Interpret recent clinical trial data of therapies for EGFR-mutant NSCLC
Attending Pathologist and Laboratory Director, Diagnostic Molecular Pathology
Medical Director, Molecular Hematopathology
Memorial Sloan Kettering Cancer Center
New York, NY
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Pathology’s (ABPath) Maintenance of Certification (MOC) program. This activity offers the following types of credit: Lifelong Learning (Part II).
By providing your ABPath Diplomate number, you consent to have ACHL submit your participation in this activity to the ABPath through the ACCME PARS system.
Completion of this activity, including the pretest, posttest, and follow-up assessments, qualifies as a medium weight MIPS improvement activity under MACRA and can be claimed as completion of IA_PSPA 28 of an Accredited Safety or Quality Improvement Program in the Quality Payment Program. Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website. You will receive additional information after completing the activity and receiving your certificate via email.